Skip to main content

Table 1 Baseline characteristics for SSc patients

From: Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications

Characteristics

SSc (n = 106)

Age, mean ± SD

55.7 ± 12.22

Sex: female

88

Diffuse SSc

29

Limited SSc

77

Disease duration† (years, mean ± SD)

12.21 ± 22.94

ILD

48 (45.28%)

Pulmonary arterial hypertension*

33 (31.13%)

MRSS, mean ± SD

9.86 ± 11.03

Digital ulcers, past or current

29/67 (43.28%)

Pitting scars

25/63 (39.68%)

Teleangiectasias

27/53 (50.94%)

joint contractures

14/57 (24.56%)

Current/former smoker

41/92 (44.57%)

Respiratory function tests, mean ± SD

 FVC (% predicted)

74.89 ± 19.54

 FEV1 (% predicted)

75.47 ± 19.35

 DLCO (% predicted)

49.74 ± 19.95

 LVEF (%)

57.19 ± 9.25

 LA (mm)

34.47 ± 5.22

 IVS (mm)

9.063 ± 1.59

 PW (mm)

8.91 ± 1.58

 LVEDD (mm)

44.50 ± 5.60

 LVESD (mm)

29.47 ± 5.74

 FS

34.08 ± 7.66

 LV mass (g, ASE)

131.30 ± 40.27

 LV mass index (g/m2)

72.16 ± 20.05

  1. †Defined as the onset of the first non-Raynaud’s manifestation; information only available for 68/106 patients
  2. *Defined as mPAP >20 mmHg, PVR>240 dynes/sec/cm−5 and PCWP ≤ 15 mmHg